Lista de obras - Emilie Thivat - Dominio Público Uruguay

A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer

artículo científico publicado en 2007

A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)

artículo científico publicado en 2008

Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors

artículo científico publicado en 2012

Brown adipose tissue activity in relation to weight gain during chemotherapy in breast cancer patients: a pilot study.

artículo científico publicado en 2014

Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.

artículo científico publicado en 2008

Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: Study protocol for case-control observational trial

artículo científico publicado en 2018

Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming.

artículo científico publicado en 2009

Cystemustine in recurrent high grade glioma.

artículo científico publicado en 2006

Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study.

artículo científico publicado en 2010

Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?

scientific article published on 01 February 2010

Effect of an intensive 3-week preoperative home rehabilitation programme in patients with chronic obstructive pulmonary disease eligible for lung cancer surgery: a multicentre randomised controlled trial

artículo científico publicado en 2017

Hibernoma: a clinical model for exploring the role of brown adipose tissue in the regulation of body weight?

artículo científico publicado en 2013

Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer - Preliminary Results From the MENOCOR Study

scientific article published on 23 October 2018

Importance of metabolic changes induced by chemotherapy on prognosis of early‐stage breast cancer patients: a review of potential mechanisms ⬇️

artículo científico publicado el 1 de diciembre de 2011

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

scientific article published on 17 August 2011

Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.

artículo científico publicado en 2005

Measurement of residual disease after neoadjuvant chemotherapy

artículo científico publicado en 2008

Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?

artículo científico publicado en 2009

Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy

artículo científico publicado en 2014

Neutrophils are immune cells preferentially targeted by retinoic acid in elderly subjects.

artículo científico publicado en 2010

Peritoneal mesothelioma: long survival with intraperitoneal chemotherapy, lanreotide and mucolytics

artículo científico publicado en 2008

Prognostic value of initial tumor parameters after metastatic relapse

artículo científico publicado en 2011

Prospective Study on Body Composition, Energy Balance and Biological Factors Changes in Post-menopausal Women with Breast Cancer Receiving Adjuvant Chemotherapy Including Taxanes

scientific article published on 20 September 2018

Quality of life after mastectomy with or without immediate breast reconstruction.

artículo científico publicado en 2017

Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial

artículo científico publicado en 2005

Temozolomide and unusual indications: review of literature.

artículo científico publicado en 2012

Temozolomide treatment of an adult with a relapsing medulloblastoma.

artículo científico publicado en 2007

The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study

artículo científico publicado en 2016

Therapeutic drug monitoring and tyrosine kinase inhibitors

artículo científico publicado en 2016

Therapeutic strategies and systemic treatment of brain melanoma metastases

artículo científico publicado en 2013

Treatment-Induced Cardiotoxicity in Breast Cancer: A Review of the Interest of Practicing a Physical Activity

scientific article published on 03 April 2019

Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments

scientific article published on 18 June 2018

Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.

artículo científico publicado en 2010

[Poor prognostic value of weight change during chemotherapy in non-metastatic breast cancer patients: causes, mechanisms involved and preventive strategies]

artículo científico publicado en 2013

[The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB]

scientific article published on 02 January 2015

Lista de obras de Emilie Thivat

A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer

A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN)

Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors

Brown adipose tissue activity in relation to weight gain during chemotherapy in breast cancer patients: a pilot study.

Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.

Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: Study protocol for case-control observational trial

Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming.

Cystemustine in recurrent high grade glioma.

Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study.

Does regional lymph node irradiation improve the outcome of N0 and pN0 breast cancer?

Effect of an intensive 3-week preoperative home rehabilitation programme in patients with chronic obstructive pulmonary disease eligible for lung cancer surgery: a multicentre randomised controlled trial

Hibernoma: a clinical model for exploring the role of brown adipose tissue in the regulation of body weight?

Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer - Preliminary Results From the MENOCOR Study

Importance of metabolic changes induced by chemotherapy on prognosis of early‐stage breast cancer patients: a review of potential mechanisms ⬇️

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.

Measurement of residual disease after neoadjuvant chemotherapy

Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?

Neurotoxicity as a prognostic factor in patients with metastatic breast cancer treated with ixabepilone as a first-line therapy

Neutrophils are immune cells preferentially targeted by retinoic acid in elderly subjects.

Peritoneal mesothelioma: long survival with intraperitoneal chemotherapy, lanreotide and mucolytics

Prognostic value of initial tumor parameters after metastatic relapse

Prospective Study on Body Composition, Energy Balance and Biological Factors Changes in Post-menopausal Women with Breast Cancer Receiving Adjuvant Chemotherapy Including Taxanes

Quality of life after mastectomy with or without immediate breast reconstruction.

Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial

Temozolomide and unusual indications: review of literature.

Temozolomide treatment of an adult with a relapsing medulloblastoma.

The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study

Therapeutic drug monitoring and tyrosine kinase inhibitors

Therapeutic strategies and systemic treatment of brain melanoma metastases

Treatment-Induced Cardiotoxicity in Breast Cancer: A Review of the Interest of Practicing a Physical Activity

Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments

Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.

[Poor prognostic value of weight change during chemotherapy in non-metastatic breast cancer patients: causes, mechanisms involved and preventive strategies]

[The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB]